Stock Price Forecast

March 12, 2021


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Viela Bio Inc chart...

About the Company

We do not have any company description for Viela Bio Inc at the moment.

Exchange

NASDAQ/NGS (GLOBAL SELECT MARKET)

$12M

Total Revenue

139

Employees

$3B

Market Capitalization

-18.73

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VIE News

Viela Bio Inc (VIE)

16d ago, source: Investing

Procedures for making available or consulting information relating to the Combined General Meeting of April 25, 2024 PARIS--(BUSINESS WIRE)--Regulatory News: Veolia ...

Viela Bio Spikes as Horizon Therapeutics Agrees to Acquire It for $3.5 Billion

3y ago, source: TheStreet.com

Shares of Viela spiked Monday after Horizon Therapeutics said it will buy the autoimmune disease drug developer for $3.5 billion. Shares of the Gaithersburg, Md.-based Viela were up 52.6% to $52. ...

Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis

3d ago, source: MedPage Today on MSN

DENVER -- An oral suspension of clean-surfaced gold nanocrystals known as CNM-Au8 was safe and well-tolerated in patients ...

Plc Astrazeneca's Net Worth

1mon ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include Viela Bio, Inc., Aevi Genomic Medicine, Inc., PhaseBio Pharmaceuticals Inc, Entasis Therapeutics Holdings Inc., ALBIREO ...

ArriVent Biopharma

2y ago, source: MedCity News

It’s the second biotech IPO of this week, following CG Oncology. Led by former Viela Bio CEO Bing Yao, ArriVent Biopharma secures rights to drugs from emerging biotech hubs, then develops them ...

Chris Nolet's Net Worth

1mon ago, source: Benzinga.com

Inc., Viela Bio, Inc., Jasper Therapeutics, Inc., and POLARITYTE, INC.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second ...

Takara Bio Inc 4974

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

2seventy bio, Inc. (TSVT)

6d ago, source: Yahoo Finance

April 01, 2024--2seventy bio, Inc. (Nasdaq: TSVT), announced today the completion of the asset purchase agreement ("APA") by Regeneron Pharmaceuticals, Inc. Under the terms of the APA, Regeneron ...

Kala Bio Inc KALA

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

THRD Third Harmonic Bio, Inc.

1d ago, source: Seeking Alpha

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases ...

bluebird bio, Inc. (BLUE)

6d ago, source: Yahoo Finance

SOMERVILLE, Mass., April 11, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of 102,700 ...

GRTS Gritstone bio, Inc.

11d ago, source: Seeking Alpha

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...